These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2183573)

  • 21. Kinetics of the human antibody response against Salmonella enterica Serovars Enteritidis and Typhimurium determined by lipopolysaccharide enzyme-linked immunosorbent assay.
    Strid MA; Dalby T; Mølbak K; Krogfelt KA
    Clin Vaccine Immunol; 2007 Jun; 14(6):741-7. PubMed ID: 17329442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and Cross-Protective Efficacy Induced by Outer Membrane Proteins from Salmonella Typhimurium Mutants with Truncated LPS in Mice.
    Liu Q; Liu Q; Zhao X; Liu T; Yi J; Liang K; Kong Q
    Int J Mol Sci; 2016 Mar; 17(3):416. PubMed ID: 27011167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
    Nys M; Cloes JM; Demonty J; Joassin L
    J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of the protective antigen in Salmonella typhimurium.
    Mates A; Yosipovici H
    Microbios; 1976; 16(64):81-90. PubMed ID: 800632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opsonophagocytic Assay To Evaluate Immunogenicity of Nontyphoidal Salmonella Vaccines.
    Ramachandran G; Boyd MA; MacSwords J; Higginson EE; Simon R; Galen JE; Pasetti MF; Levine MM; Tennant SM
    Clin Vaccine Immunol; 2016 Jun; 23(6):520-523. PubMed ID: 27030587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conjugation of tetanus toxoid with Salmonella typhimurium PTCC 1735 O-specific polysaccharide and its effects on production of opsonizing antibodies in a mouse model.
    Jazani NH; Worobec E; Shahabi S; Nejad GB
    Can J Microbiol; 2005 Apr; 51(4):319-24. PubMed ID: 15980894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immune response in rabbits inoculated with Salmonella typhimurium].
    Parma AE; Cerone S; Erpelding A; Margni RA
    Rev Argent Microbiol; 1980; 12(3):100-4. PubMed ID: 6755553
    [No Abstract]   [Full Text] [Related]  

  • 29. [The determination of the antibodies and the somatic O-antigen of Salmonella group B by using the complement-bound lysis of liposomes].
    Skopinskaia SN; Iarkov SP; Rubtsov IV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):84-8. PubMed ID: 1696765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive African nontyphoidal Salmonella requires high levels of complement for cell-free antibody-dependent killing.
    Goh YS; MacLennan CA
    J Immunol Methods; 2013 Jan; 387(1-2):121-9. PubMed ID: 23085530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strain dependent variation of delayed-type hypersensitivity in Salmonella typhimurium infected mice.
    Killar L; Eisenstein TK
    Adv Exp Med Biol; 1983; 162():297-302. PubMed ID: 6346823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically conferred defect in anti-Salmonella antibody formation renders CBA/N mice innately susceptible to Salmonella typhimurium infection.
    O'Brien AD; Scher I; Metcalf ES
    J Immunol; 1981 Apr; 126(4):1368-72. PubMed ID: 7009738
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides.
    Robbins JB; Chu C; Schneerson R
    Clin Infect Dis; 1992 Aug; 15(2):346-61. PubMed ID: 1381621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine immune responses to Salmonella lipopolysaccharide: oral administration of whole bacteria to C3H/HeJ mice induces secondary anti-LPS responses, especially of the IgA isotype.
    Jirillo E; Kiyono H; Michalek SM; McGhee JR
    J Immunol; 1984 Apr; 132(4):1702-11. PubMed ID: 6366051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunization against salmonella typhimurium infection in mice. Chemical composition and protecting activity of different extracts from salmonella R mutants (author's transl)].
    Müller W; Schlecht S; Westphal O
    Zentralbl Bakteriol A; 1980; 248(1):64-80. PubMed ID: 7008450
    [No Abstract]   [Full Text] [Related]  

  • 36. Multi-immunogenic outer membrane vesicles derived from an MsbB-deficient Salmonella enterica serovar typhimurium mutant.
    Lee SR; Kim SH; Jeong KJ; Kim KS; Kim YH; Kim SJ; Kim E; Kim JW; Chang KT
    J Microbiol Biotechnol; 2009 Oct; 19(10):1271-9. PubMed ID: 19884791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
    Jiang H; Hu Y; Yang M; Liu H; Jiang G
    Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A conditionally lethal mutant of Salmonella Typhimurium induces a protective response in mice.
    Hidalgo AA; Villagra NA; Jerez SA; Fuentes JA; Mora GC
    Biochem Biophys Res Commun; 2016 Feb; 470(2):313-318. PubMed ID: 26792728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of structure to function in bacterial endotoxins: serologically cross-reactive components and their effect on protection of mice against some gram-negative infections.
    Ng AK; Chen CL; Chang CM; Nowotny A
    J Gen Microbiol; 1976 May; 94(1):107-16. PubMed ID: 778329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Protection against experimental Salmonella typhimurium infection in mice. Immunostimulating activity of heterologous Salmonella S-forms, R-mutants, lipopolysaccharides and muramyl dipeptide in vaccines combined with S. typhimurium].
    Schlecht S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):414-25. PubMed ID: 6385567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.